Florida Cancer Specialists & Research Institute Contributes to Milestone that Expands Treatment Options For Patients With Recurrent Ovarian Cancer
Late-Phase Research Presented at Society of Gynecologic Oncology Annual Meeting FORT MYERS, Fla., April 13, 2026 /PRNewswire/ -- Late-phase clinical research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) has led to the U.S. Food & Drug...
View original →